10/09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

10/09/2024

Sep 10, 2024, 13:50 | Blog
Francisco J. Esteva: The importance of improving ctDNA methodologies
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Sep 10, 2024, 13:49 | Blog
The Institute of Cancer Research - Lucas’ Legacy to help fund research into childhood brain tumours
The Institute of Cancer Research shared on LinkedIn: "'I’m so sorry Lucas that I couldn’t protect…
Sep 10, 2024, 13:48 | Blog
Angela Mastronuzzi: Pediatric Hematology/Oncology Nurses Day
Angela Mastronuzzi shared on LinkedIn: "On September 8 we celebrate Pediatric Hematology/Oncology Nurses Day I am extremely…
Sep 10, 2024, 13:45 | Societies
Rami Manochakian's key highlights from WCLC24
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Sep 10, 2024, 13:44 | Societies
There is still time to register for ESMO24
ESMO – European Society for Medical Oncology shared on LinkedIn: “ With ESMO24 just around…
Sep 10, 2024, 13:43 | Insight
Douglas Flora: Olalekan Ajayi is joining the AI in Precision Oncology Editorial Board
Douglas Flora shared a post on LinkedIn: “We are thrilled to announce that Olalekan Ajayi, is…
Sep 10, 2024, 13:42 | Blog
Vivek Subbiah: A morning walk to support melanoma research
Vivek Subbiah posted on X by himself adding: "Amazing day for a morning walk to…
Sep 10, 2024, 13:42 | Insight
Ramandeep Arora's symposium on ‘Patient Tracking as a Tool to Reduce Treatment Abandonment in LMICS’
International Society of Paediatric Oncology - SIOP shared on LinkedIn: “Don't miss Ramandeep Arora's symposium…
Sep 10, 2024, 13:41 | Blog
Wafik S. El-Deiry: Looking forward to upcoming Legorreta Cancer Center Annual Membership Retreat
Wafik S. El-Deiry shared on X: “Looking forward to upcoming Legorreta Cancer Center Annual Membership…
Sep 10, 2024, 13:38 | Insight
Agenus‘s latest data from the clinical trial of BOT/BAL in refractory sarcomas at ESMO24
Agenus shared on LinkedIn: “The Agenus team is headed to Barcelona for ESMO24. This Friday,…
All: 117 Posts: 41 - 50
Special Coverage